Siffert Joao MD
Insider CIK 1534986 · AVXS Director · DSGN President and CEO, Director · ABEO Chief Executive Officer, Director · AVNR SVP, R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DSGN Design Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 415,000 | — | $0 | 415,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | P Buy | 2022-12-20 | 2022-12-21 | 6,300 | $8.38 | $52.8K | 132,619 | SEC↗ |
| DSGN Design Therapeutics, Inc. | P Buy | 2022-12-19 | 2022-12-21 | 1,150 | $8.47 | $9.7K | 126,319 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-02 | 475,000 | — | $0 | 475,000 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award deriv | 2020-05-20 | 2020-05-22 | 72,296 | — | $0 | 72,296 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award | 2020-05-20 | 2020-05-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award deriv | 2020-03-16 | 2020-03-18 | 127,704 | — | $0 | 127,704 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award deriv | 2019-04-09 | 2019-04-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award deriv | 2019-02-11 | 2019-04-18 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award deriv | 2019-01-31 | 2019-04-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 2,905 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 7,755 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer | 2018-05-15 | 2018-05-15 | 1,106 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2018-03-13 | 2018-03-30 | 2,905 | — | $0 | 2,905 | SEC↗ |
| AVXS AveXis, Inc. | A Award | 2018-03-13 | 2018-03-30 | 1,106 | — | $0 | 1,106 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2017-05-30 | 2017-06-01 | 2,454 | — | $0 | 2,454 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2017-05-30 | 2017-06-01 | 5,301 | — | $0 | 5,301 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise deriv | 2014-12-18 | 2014-12-22 | 32,291 | — | $0 | 0 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | F Tax w/h | 2014-12-18 | 2014-12-22 | 19,204 | $16.99 | $326.3K | 329,697 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-12-18 | 2014-12-22 | 15,505 | $16.93 | $262.5K | 314,192 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise | 2014-12-18 | 2014-12-22 | 32,291 | $2.59 | $83.6K | 348,901 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-11-10 | 2014-11-12 | 34,825 | — | $0 | 316,610 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-11-10 | 2014-11-12 | 59,231 | — | $0 | 281,785 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-10-24 | 2014-10-24 | 8,426 | $11.80 | $99.4K | 222,554 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise deriv | 2014-05-28 | 2014-05-30 | 10,547 | — | $0 | 24,609 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-05-28 | 2014-05-30 | 13,547 | $5.18 | $70.2K | 230,980 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-02-12 | 2014-02-14 | 80,750 | — | $0 | 190,980 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-02-12 | 2014-02-14 | 43,000 | — | $0 | 233,980 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2013-12-18 | 2013-12-20 | 5,970 | $2.63 | $15.7K | 110,230 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award deriv | 2013-12-13 | 2013-12-17 | 47,500 | — | $0 | 47,500 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise deriv | 2013-09-18 | 2013-09-19 | 21,094 | — | $0 | 35,156 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise | 2013-09-18 | 2013-09-19 | 21,094 | $1.85 | $39.0K | 137,294 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2013-09-18 | 2013-09-19 | 21,094 | $4.22 | $89.0K | 116,200 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award deriv | 2012-12-17 | 2012-12-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2012-12-17 | 2012-12-19 | 34,875 | — | $0 | 116,200 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2012-12-17 | 2012-12-19 | 49,125 | — | $0 | 81,325 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | P Buy | 2012-05-10 | 2012-05-14 | 2,700 | $2.96 | $8.0K | 32,200 | SEC↗ |